← Open Payments lookup

DANIEL BEGEL: Open Payments

NPI 1376609149 · SANTA MONICA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$809 in 26 payments from 8 companies in 2025. Trend: 2023 $698 · 2024 $512 · 2025 $809

Food & beverage: $809
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.4$208
Alkermes, Inc.7$200
Neurocrine BioSciences, Inc.5$156
E.R. Squibb & Sons, L.L.C.2$57
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$55
Teva Pharmaceuticals USA, Inc.2$53
Lundbeck LLC2$45
ABBVIE INC.2$34

Products named: REXULTI, ARISTADA, INGREZZA, CAPLYTA, UZEDY, VIVITROL, VRAYLAR, COBENFY.

Industry payments across CA — which companies pay providers there.